COVALENT-101: Phase I Study of BMF-219, a Covalent Menin Inhibitor, in adult patients with AML, ALL (with KMT2A/ MLL1r, NPM1 Mutations), DLBCL, MM, and CLL/SLL (NCT05153330)Brian Hill,Jacqueline Barrientos,Juan Miguel Bergua Burgues,John Byrd, Jimena Cannata, Catherine C. Coombs, Herbert Eradat,Pau Montesinos,Daniel Morillo, Lawrence Morris,Olalekan Oluwole,Ricardo Parrondo,Javier Pinilla-Ibarz,Joseph Tuscano,Alex Cacovean, Courtney Follit, Mona Vimal,Steve Morris,Thomas Butler,William WierdaLEUKEMIA & LYMPHOMA（2023）引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
